drugset / Trial / NCT07231744
Study of STLX-2012 in Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this research is to establish the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a single IV dose of STLX-2012.
Timeline
- Start
- 2026-10
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STLX-2012 | Unknown | — | Intravenous |
Indications
No indication recorded.